FundamentalVR has raised £16.4 million to accelerate medical skill-transfer and increase surgical proficiency through its medical simulation platform, Fundamental Surgery.
The platform combines virtual reality and haptics through data, artificial intelligence and multimodal learning. Its patented HapticVRTM technology mimics the physical touch of surgical actions which allows users to experience the sights, sounds and physical sensations of real-life surgery.
Scalable and hardware agnostic, the platform immerses users in a controlled training environment that lowers the surgical risk to patients.
Deployed in over 30 countries, its simulations help life science, pharmaceutical and medical device companies deploy medical innovations in disciplines from ophthalmology to robotics and gene therapy.
The transaction was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. It will drive further US growth at the company and brings its total funding to over $30m.
“Our platform can conduct a walkthrough of a procedure through to a full operation, facilitating surgical skills transfer – which is why we have been enthusiastically embraced throughout the medical industry, from med-device manufacturers to pharmaceuticals,” says co-founder and CEO Richard Vincent.
“Our immersive environments transform surgical skills acquisition in a scalable, low-cost, multiuser way. We are excited to scale our vision of creating a medical education environment unhindered by borders.”
As part of the transactions, Drew Burdon of EQT Life Sciences will join the board of directors.